Skip to content

Prophylactic application of PEG-rhG-CSF during chemoradiotherapy for cervical cancer

Prophylactic application of PEG-rhG-CSF during chemoradiotherapy for cervical cancer

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900026309
Enrollment
Unknown
Registered
2019-09-29
Start date
2019-10-01
Completion date
Unknown
Last updated
2019-09-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cervical cancer

Interventions

Group A :PEG-rhG-CSF
Group B:PEG-rhG-CSF plus rhG-CSF

Sponsors

Affiliated Cancer Hospital of Zhengzhou University, Cancer Hospital of Henan Province
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1) Cervical cancer patients aged over 18 years and less than 75 years who had received previous radiotherapy and chemotherapy; 2) Patients need radical radiotherapy or concurrent chemoradiotherapy. 3) Physical condition (KPS) score (> 70); 4) The KPS score (> 70) for the predicted survival period of more than 8 months. 5) The expected survival time is more than 6 months. 6) No obvious symptoms of hematological diseases; 7) Subject's informed consent.

Exclusion criteria

Exclusion criteria: 1) Currently, there are uncontrollable infections or antibiotic treatment within 72 hours before chemotherapy. 2) any abnormal proliferation of bone marrow and other abnormal hematopoietic function; 3) allergic to biological products derived from this product or other genetically engineered Escherichia coli; 4) those who suffer from mental or nervous system diseases and cannot cooperate; 5) Pregnant or lactating women; women of gestational age who refuse or accept contraceptive measures; 6) One to be considered not suit for be included in the study by the researchers.

Design outcomes

Primary

MeasureTime frame
ANC;

Countries

China

Contacts

Public ContactShuxia Cheng

Affiliated Cancer Hospital of Zhengzhou University, Cancer Hospital of He'nan Province

13653718356@136.com+86 13653718356

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 5, 2026